News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,609 Results
Type
Article (5145)
Company Profile (25)
Press Release (227439)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (82386)
Career Advice (464)
Deals (15086)
Drug Delivery (8)
Drug Development (19213)
Employer Resources (30)
FDA (3698)
Job Trends (3933)
News (120498)
Policy (7536)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (296)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14859)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (40)
Approvals (3798)
Artificial intelligence (81)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2885)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (889)
Cardiovascular disease (62)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16795)
Collaboration (353)
Compensation (373)
Complete response letters (8)
COVID-19 (312)
CRISPR (13)
C-suite (341)
Cystic fibrosis (28)
Data (1331)
Denatured (1)
Depression (21)
Diabetes (81)
Diagnostics (2120)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42785)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39233)
Executive appointments (426)
FDA (4439)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (343)
Gene editing (24)
Generative AI (5)
Gene therapy (104)
GLP-1 (145)
Government (425)
Guidances (197)
Healthcare (5052)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (338)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7886)
IRA (3)
Job creations (1126)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (11)
Layoffs (109)
Leadership (5)
Legal (2339)
Liver cancer (21)
Longevity (2)
Lung cancer (94)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (52)
Medical device (3921)
Medtech (3931)
Mergers & acquisitions (7608)
Metabolic disorders (221)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (13)
Neuroscience (543)
NextGen: Class of 2026 (1678)
Non-profit (731)
Now hiring (5)
Obesity (86)
Opinion (33)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (51)
Partnered (6)
Patents (53)
Patient recruitment (98)
Peanut (6)
People (25264)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase 1 (5036)
Phase 2 (7271)
Phase 3 (5829)
Pipeline (1977)
Policy (17)
Postmarket research (628)
Preclinical (1961)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (110)
Rare diseases (181)
Real estate (1887)
Recruiting (8)
Regulatory (5562)
Reports (17)
Research institute (311)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (54)
Series B (55)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1023)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (10)
Weight loss (30)
Women's health (6)
Date
Today (29)
Last 7 days (147)
Last 30 days (541)
Last 365 days (8931)
2026 (814)
2025 (9058)
2024 (11062)
2023 (13247)
2022 (18717)
2021 (19750)
2020 (18282)
2019 (13255)
2018 (10243)
2017 (10031)
2016 (9180)
2015 (12155)
2014 (9613)
2013 (7716)
2012 (8350)
2011 (8813)
2010 (8642)
Location
Africa (187)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11841)
Australia (1694)
California (3545)
Canada (1139)
China (168)
Colorado (144)
Connecticut (163)
Delaware (70)
Europe (25688)
Florida (543)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (106)
Iowa (9)
Japan (167)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2818)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1023)
New Mexico (5)
New York (818)
North Carolina (480)
North Dakota (4)
Northern California (1855)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (280)
South Carolina (17)
Southern California (1307)
Tennessee (61)
Texas (483)
United States (12366)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,609 Results for "sumitomo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
December 9, 2025
·
14 min read
Press Releases
Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
November 3, 2025
·
9 min read
Press Releases
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
July 30, 2025
·
4 min read
Pharm Country
Sumitomo Corporation makes investment in Brazilian insect protein production and biotechnology company Cyns to Support Next Generation Sustainable Feed Production
Sumitomo Corporation, through Sumitomo Corporation do Brasil S.A. announced a joint investment in a Seed round for Cyns, a biotechnology company located in Sao Paulo, Brazil, to unlock the next chapter of black soldier fly farming in Latin America.
January 30, 2024
·
4 min read
Press Releases
Sumitomo Pharma America Announces that Nuvisertib (TP-3654) Has Received FDA Fast Track Designation for the Treatment of Myelofibrosis
June 13, 2025
·
5 min read
Press Releases
Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
April 30, 2025
·
7 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
·
8 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Drug Development
Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
Sumitomo Pharma America, Inc., (SMPA) today announced the presentation of data from URO-901-3005, a Phase 3 randomized, double-blind, parallel-group, fixed-dose study evaluating the efficacy, safety, and tolerability of vibegron.
May 7, 2024
·
8 min read
1 of 23,261
Next
